Jim Simons Adverum Biotechnologies, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.75 - $1.26 $410,933 - $690,367	547,911 Added 41.2%	1,877,652 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.33 $169,650 - $263,523	113,100 Added 9.3%	1,329,741 $2 Million
Q2 2023 Aug 11, 2023	BUY	$0.68 - $1.59 $54,332 - $127,041	79,900 Added 7.03%	1,216,641 $1.93 Million
Q1 2023 May 12, 2023	BUY	$0.62 - $0.85 $38,750 - $53,125	62,500 Added 5.82%	1,136,741 $815,000
Q4 2022 Feb 13, 2023	SELL	$0.54 - $10.3 $23,868 - $455,260	-44,200 Reduced 3.95%	1,074,241 $623,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $24,384 - $245,872	25,400 Added 2.32%	1,118,441 $1.06 Million
Q2 2022 Aug 12, 2022	BUY	$0.81 - $1.34 $564,246 - $933,444	696,600 Added 175.71%	1,093,041 $1.31 Million
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $299,795 - $475,285	-243,736 Reduced 38.07%	396,441 $519,000
Q4 2021 Feb 11, 2022	SELL	$1.74 - $2.4 $811,884 - $1.12 Million	-466,600 Reduced 42.16%	640,177 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $618,793 - $1.07 Million	297,497 Added 36.76%	1,106,777 $2.4 Million
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $2.29 Million - $7.21 Million	682,703 Added 539.36%	809,280 $2.83 Million
Q1 2021 May 13, 2021	BUY	$9.26 - $14.36 $1.17 Million - $1.82 Million	126,577 New	126,577 $1.25 Million
Q4 2020 Feb 10, 2021	SELL	$9.84 - $14.26 $4.3 Million - $6.23 Million	-436,588 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$10.3 - $21.64 $1.51 Million - $3.17 Million	-146,360 Reduced 25.11%	436,588 $4.5 Million
Q2 2020 Aug 13, 2020	SELL	$8.53 - $25.64 $4.28 Million - $12.9 Million	-501,200 Reduced 46.23%	582,948 $12.2 Million
Q1 2020 May 14, 2020	SELL	$7.98 - $16.32 $2.97 Million - $6.07 Million	-371,700 Reduced 25.53%	1,084,148 $10.6 Million
Q4 2019 Feb 13, 2020	SELL	$5.12 - $12.22 $6.33 Million - $15.1 Million	-1,237,152 Reduced 45.94%	1,455,848 $16.8 Million
Q3 2019 Nov 13, 2019	SELL	$5.24 - $15.89 $6.1 Million - $18.5 Million	-1,164,500 Reduced 30.19%	2,693,000 $14.7 Million
Q2 2019 Aug 12, 2019	BUY	$5.1 - $11.89 $322,320 - $751,448	63,200 Added 1.67%	3,857,500 $45.9 Million
Q1 2019 May 14, 2019	BUY	$3.03 - $6.02 $231,894 - $460,728	76,533 Added 2.06%	3,794,300 $19.9 Million
Q4 2018 Feb 13, 2019	BUY	$2.87 - $5.92 $10.7 Million - $22 Million	3,717,767 New	3,717,767 $11.7 Million

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account